Smartleaf Asset Management
OLMA icon

Smartleaf Asset Management’s Olema Pharmaceuticals OLMA Stock Holding History

Smartleaf Asset Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-40
Closed -$488 – 3763
2026
Q2 		$488 Hold
40
– – ﹤0.01% 3203
2026
Q1 		$537 Buy
+40
New +$890 ﹤0.01% 3214

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
SEB Asset Management
SEB Asset Management Stockholm $27B AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Smartleaf Asset Management's OLMA Position: Q3 2026 in Review

Smartleaf Asset Management sold out of Olema Pharmaceuticals (OLMA) in Q3 2026, closing a stake of 40 shares — an estimated $488 sold.

Smartleaf Asset Management first reported a position in OLMA in Q1 2026 and held it in 2 quarters. The position peaked at $537 in Q1 2026. 73 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.

  • Smartleaf Asset Management reported no remaining Olema Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Smartleaf Asset Management sold 40 Olema Pharmaceuticals shares in Q3 2026, an estimated $488.
  • Smartleaf Asset Management first reported a position in Olema Pharmaceuticals in Q1 2026 and held it in 2 quarters.
  • Smartleaf Asset Management's Olema Pharmaceuticals position peaked at $537 in Q1 2026.
  • 73 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.